AdvanCell Isotopes Pty Ltd

0 followers

‌

AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.

Industries

Biotechnology, Clinical Trials

Employees

11-50

Links

Org chart

Andrew Adamovich

Chief Executive Officer

Collapse

Julian F. Kelly

Chief Scientist (Nuclear & Chemical)

Kevin Kuan

SVP Technical Operations

Simon Puttick

CSO/COO

Vanessa Worsfold

Head Of Quality And Head Of Marketing

Sheruna Naidoo

Vice President Technical Operations

Feifei Liu

Director Preclinical Science

Gary Li

Chief Strategy Officer

Teams

Research and Development

7 people · 0 jobs

Leadership Team

3 people · 0 jobs

Offices

This company has no offices yet

Similar companies

Peptone

2 followers

Tango Therapeutics

3 followers

Roche

341 followers

Arthritis Knee Pain Centers

2 followers

AbbVie

270 followers

FUJIFILM Diosynth Biotechnologies

16 followers

Cellares

4 followers

Amgen

274 followers

Elanco

26 followers

Pierre Fabre

15 followers

Kedrion Biopharma

19 followers

Explore companies